Extended Access Program and Retrospective Chart Review for Lorcaserin in Dravet Syndrome and Other Refractory Epilepsies
Extended Access Program and Retrospective Chart Review for Lorcaserin in Dravet Syndrome and Other Refractory Epilepsies
The primary purpose of this study is to provide continued access of lorcaserin to participants with Dravet syndrome and other refractory epilepsies.
Inclusion Criteria:
Exclusion Criteria:
None
esi_medinfo@eisai.com+1-888-274-2378
Los Angeles, California 90095, United States
Washington D.C., District of Columbia 20019, United States
Miami, Florida 33155, United States
Hackensack, New Jersey 07601, United States
Philadelphia, Pennsylvania 19107, United States
Houston, Texas 77030, United States